Aclaris' IPO latest to price below range

Aclaris Therapeutics Inc. (NASDAQ:ACRS) gained $0.05 to $11.05 in its first day of trading after raising $55 million through the sale of 5 million shares at $11 in an IPO underwritten by Jefferies; Citigroup; and William Blair. The IPO price valued Aclaris at $213.5 million.

Aclaris proposed to raise up $86.3 million in August. Last month, it said it hoped to sell 5 million shares at $14-$16. At $15, it would have raised $75 million and been valued at $291.1 million. ...